Endothelial Damage and Hemostatic Markers in Patients with Uncomplicated Mild-to-Moderate Hypertension and Relationship with Risk Factors, Clinical and Applied Thrombosis/Hemostasis, vol.70, issue.3, pp.147-159, 2005. ,
DOI : 10.1016/S0021-9150(98)00163-4
Hemostasis in normotensive and hypertensive men, Journal of Hypertension, vol.16, issue.7, pp.917-923, 1998. ,
DOI : 10.1097/00004872-199816070-00004
Does hypertension confer a hypercoagulable state?, Journal of Hypertension, vol.16, issue.7, pp.913-916, 1998. ,
DOI : 10.1097/00004872-199816070-00003
Hemostasis imbalance in experimental hypertension, stroke but not with coronary heart disease in the elderly: the Three-City cohort study, pp.169-178, 2002. ,
The Link Between Vascular Features and Thrombosis, Annual Review of Physiology, vol.73, issue.1, pp.503-514, 2011. ,
DOI : 10.1146/annurev-physiol-012110-142300
Contributions of extravascular and intravascular cells to fibrin network formation, structure, and stability, Blood, vol.114, issue.23, pp.4886-4896, 2009. ,
DOI : 10.1182/blood-2009-06-228940
Thrombin generation by apoptotic vascular smooth muscle cells, Blood, vol.89, pp.4378-4384, 1997. ,
Thrombin generation in vascular tissue, Journal of Thrombosis and Haemostasis, vol.18, issue.Suppl. 1, pp.60-67, 2006. ,
DOI : 10.1161/01.ATV.18.2.250
Tissue Factor Pathway Inhibitor: A New Link Among Arterial Stiffness, Pulse Pressure, and Coagulation in Postmenopausal Women, Arteriosclerosis, Thrombosis, and Vascular Biology, vol.31, issue.5, pp.1226-1232, 2011. ,
DOI : 10.1161/ATVBAHA.110.221911
Selective isolation of rat aortic wall layers and their cell types in culture???Application to converting enzyme activity measurement, Tissue and Cell, vol.26, issue.6 ,
DOI : 10.1016/0040-8166(94)90043-4
Calibrated Automated Thrombin Generation Measurement in Clotting Plasma, Pathophysiology of Haemostasis and Thrombosis, vol.33, issue.1, pp.4-15, 2003. ,
DOI : 10.1159/000071636
Phenotyping the haemostatic system by thrombography???potential for the estimation of thrombotic risk, Thrombosis Research, vol.114, issue.5-6, pp.539-545, 2004. ,
DOI : 10.1016/j.thromres.2004.06.017
Pathophysiology of the proatherothrombotic state in the metabolic syndrome, Frontiers in Bioscience, vol.2, issue.1, pp.194-208, 2010. ,
DOI : 10.2741/s57
The metabolic syndrome and the risk of arterial and venous thrombosis, Thrombosis Research, vol.122, issue.6, pp.727-762, 2008. ,
DOI : 10.1016/j.thromres.2007.09.010
Metabolic Syndrome: Comparison of Occurrence Using Three Definitions in Hypertensive Patients, Clinical Medicine & Research, vol.9, issue.1, pp.26-31, 2010. ,
DOI : 10.3121/cmr.2010.902
Metabolic disorders associated with uncontrolled hypertension. Skaraborg hypertension and diabetes project, Diabetes, Obesity and Metabolism, vol.96, issue.6, pp.379-87, 2003. ,
DOI : 10.1016/S0002-9149(99)80444-5
Preventing coronary events by optimal control of blood pressure and lipids in patients with the metabolic syndrome, The American Journal of Cardiology, vol.91, issue.12, pp.91-1421, 2003. ,
DOI : 10.1016/S0002-9149(03)00392-8
Hypertension is the Most Important Component of Metabolic Syndrome in the Association With Ischemic Heart Disease in Taiwanese Type 2 Diabetic Patients, Circulation Journal, vol.72, issue.9, pp.72-1419, 2008. ,
DOI : 10.1253/circj.CJ-08-0009
Metabolic Syndrome Affects Cardiovascular Risk Profile and Response to Treatment in Hypertensive Postmenopausal Women, Hypertension, vol.52, issue.5, pp.52-865, 2008. ,
DOI : 10.1161/HYPERTENSIONAHA.108.110478
Blood pressure control and components of the metabolic syndrome: the GOOD survey, Cardiovascular Diabetology, vol.8, issue.1, p.51, 2009. ,
DOI : 10.1186/1475-2840-8-51
Pathophysiological role of leptin in obesity-related hypertension, Journal of Clinical Investigation, vol.105, issue.9, pp.105-1243, 2000. ,
DOI : 10.1172/JCI8341
Contrasting blood pressure effects of obesity in leptin-deficient ob/ob mice and agouti yellow obese mice, J Hypertens, vol.17, pp.1949-53, 1999. ,
Sleep modulates hypertension in leptin-deficient obese mice, Hypertension, pp.53-251, 2009. ,
Leptin regulates neointima formation after arterial injury through mechanisms independent of blood pressure and the leptin receptor/STAT3 signaling pathways involved in energy balance, Arterioscler Thromb Vasc Biol, pp.27-70, 2007. ,
mice, American Journal of Physiology-Heart and Circulatory Physiology, vol.295, issue.4, pp.295-1634, 2008. ,
DOI : 10.1097/00041552-200301000-00016
URL : https://hal.archives-ouvertes.fr/hal-01341519
Adiposity and Cardiovascular Disorders: Disturbance of the Regulatory System Consisting of Humoral and Neuronal Signals, Circulation Research, vol.101, issue.1, pp.27-39, 2007. ,
DOI : 10.1161/CIRCRESAHA.107.151621
Mechanisms of insulin resistance in rat models of hypertension and their relationships with salt sensitivity, Journal of Hypertension, vol.17, issue.9, pp.1229-1266, 1999. ,
DOI : 10.1097/00004872-199917090-00001
Review: Insulin and endothelin: an interplay contributing to hypertension development?, J Clin Endocrinol Metab, pp.92-379, 2007. ,
Insulin infusion induces endothelin-1-dependent hypertension in rats, American Journal of Physiology-Endocrinology and Metabolism, vol.287, issue.5, pp.287-948, 2004. ,
DOI : 10.1006/jmcc.2002.2111
Endothelin-1 response to glucose and insulin among African Americans, Journal of the American Society of Hypertension, vol.4, issue.5, pp.227-262, 2010. ,
DOI : 10.1016/j.jash.2010.07.004
Increased oxidative stress in obesity and its impact on metabolic syndrome, J Clin Invest, vol.114, pp.1752-61, 2004. ,
A high-fat, refined-carbohydrate diet induces endothelial dysfunction and oxidant/antioxidant imbalance and depresses NOS protein expression, Journal of Applied Physiology, vol.98, issue.1, pp.98-203, 2005. ,
DOI : 10.1016/S0895-7061(98)00238-6
Pathophysiology of obesity hypertension, Current Hypertension Reports, vol.44, issue.2, pp.139-186, 2000. ,
DOI : 10.1161/01.HYP.25.4.888
Angiotensin II, mechanotransduction, and pulsatile arterial hemodynamics in hypertension, American Journal of Physiology-Heart and Circulatory Physiology, vol.276, issue.5, pp.297-1567, 2009. ,
DOI : 10.1159/000102955
Insulin resistance and hypertension, American Journal of Physiology-Heart and Circulatory Physiology, vol.286, issue.5, pp.1597-602, 2004. ,
DOI : 10.1161/01.CIR.101.13.1539
Molecular Genetics of Experimental Hypertension and the Metabolic Syndrome: From Gene Pathways to New Therapies, Hypertension, vol.49, issue.5, pp.49-941, 2007. ,
DOI : 10.1161/HYPERTENSIONAHA.107.086900
Effects of telmisartan on adiponectin levels and body weight in hypertensive patients with glucose intolerance, Metabolism, vol.57, issue.10, pp.57-1473, 2008. ,
DOI : 10.1016/j.metabol.2008.05.019
Physiology and Pathophysiology of the Adipose Tissue Renin-Angiotensin System, Hypertension, vol.35, issue.6, pp.35-1270, 2000. ,
DOI : 10.1161/01.HYP.35.6.1270
Location and regulation of rat angiotensinogen messenger RNA., Hypertension, vol.11, issue.6_Pt_2, pp.11-591, 1988. ,
DOI : 10.1161/01.HYP.11.6.591
Evidence for a local renin angiotensin system in primary cultured human preadipocytes, International Journal of Obesity, vol.23, issue.4, pp.336-377, 1999. ,
DOI : 10.1038/sj.ijo.0800821
Characterization of renin activity in brown adipose tissue, American Journal of Physiology-Cell Physiology, vol.34, issue.3, pp.989-99, 1997. ,
DOI : 10.1210/edrv-1-4-365
Characterization and regulation of angiotensin II receptors in rat adipose tissue. Angiotensin receptors in adipose tissue, Adv Exp Med Biol, pp.396-435, 1996. ,
Aldosterone: Role in the Cardiometabolic Syndrome and Resistant Hypertension, Progress in Cardiovascular Diseases, vol.52, issue.5, pp.52-401, 2010. ,
DOI : 10.1016/j.pcad.2009.12.004
Adipokines and cardiometabolic function: How are they interlinked?, Regulatory Peptides, vol.164, issue.2-3, pp.164-133, 2010. ,
DOI : 10.1016/j.regpep.2010.06.008
Adiponectin acts as an endogenous antithrombotic factor, Arterioscler Thromb Vasc Biol, vol.26, pp.224-254, 2006. ,
Adiponectin diminishes platelet aggregation and sCD40L release. Potential role in the metabolic syndrome, American Journal of Physiology-Endocrinology and Metabolism, vol.91, issue.5, pp.298-1072, 2011. ,
DOI : 10.1097/00005344-199200193-00006
Serum leptin in the development of insulin resistance and other disorders in the metabolic syndrome, Biomedical Papers, vol.149, issue.1, pp.149-119, 2005. ,
DOI : 10.5507/bp.2005.014
Low levels of adiponectin predict worsening of arterial morphology and function, Atherosclerosis, vol.194, issue.2, pp.194-147, 2007. ,
DOI : 10.1016/j.atherosclerosis.2006.11.044
Upregulation of monocyte tissue factor activity is significantly associated with carotid intima-media thickness in patients with metabolic syndrome, J Atheroscler Thromb, vol.18, pp.475-86, 2011. ,
Regulation of tissue factor gene expression in obesity, Blood, vol.98, issue.12, pp.98-3353, 2001. ,
DOI : 10.1182/blood.V98.12.3353
Protective role of ghrelin against carbon tetrachloride (CCl4)-induced coagulation disturbances in rats, Regulatory Peptides, vol.166, issue.1-3, pp.139-181, 2011. ,
DOI : 10.1016/j.regpep.2010.10.009
Enhancement of the Coagulation System in Spontaneously Hypertensive and Hyperlipidemic Rats, Journal of Atherosclerosis and Thrombosis, vol.12, issue.4, pp.12-191, 2005. ,
DOI : 10.5551/jat.12.191
Heritability of Clot Formation, Morphology, and Lysis: The EuroCLOT Study, Arteriosclerosis, Thrombosis, and Vascular Biology, vol.27, issue.12, pp.27-2783, 2007. ,
DOI : 10.1161/ATVBAHA.107.153221
A Novel Pathway to the Manifestations of Metabolic Syndrome, Obesity Research, vol.107, issue.Suppl 3, pp.180-186, 2004. ,
DOI : 10.1161/01.CIR.0000066907.83923.32
Plasma von Willebrand Factor and the Development of the Metabolic Syndrome in Patients with Hypertension, The Journal of Clinical Endocrinology & Metabolism, vol.89, issue.11, pp.89-5377, 2004. ,
DOI : 10.1210/jc.2004-0616
Atherothrombotic Risk Factors in Subjects with a Family History of Stroke, Cerebrovascular Diseases, vol.14, issue.3-4, pp.153-60, 2002. ,
DOI : 10.1159/000065677
Diabetes mellitus as a prothrombotic condition, Journal of Internal Medicine, vol.96, issue.2, pp.157-72, 2007. ,
DOI : 10.1161/01.CIR.99.2.224
Endothelial and Antithrombotic Actions of HDL, Circulation Research, vol.98, issue.11, pp.98-1352, 2006. ,
DOI : 10.1161/01.RES.0000225982.01988.93
Plasminogen activator inhibitor type 1 is increased in the arterial wall of type II diabetic subjects, Arterioscler Thromb Vasc Biol, vol.21, pp.1378-82, 2001. ,
Association of blood pressure with fibrinolytic potential in the Framingham offspring population, Circulation, pp.101-264, 2000. ,
Plasminogen activator inhibitor-type 1: its plasma determinants and relation with cardiovascular risk, Thrombosis and Haemostasis, pp.91-861, 2004. ,
DOI : 10.1160/TH03-08-0546
Very low density lipoprotein-mediated signal transduction and plasminogen activator inhibitor type 1 in cultured HepG2 cells, Circ Res, vol.85, pp.208-225, 1999. ,
Insulin continues to induce plasminogen activator inhibitor 1 gene expression in insulin-resistant mice and adipocytes, Mol Med, vol.6, pp.680-92, 2000. ,
Impaired spontaneous thrombolytic activity measured by global thrombosis test in males with metabolic syndrome, Thrombosis Research, vol.129, issue.4, 2011. ,
DOI : 10.1016/j.thromres.2011.06.019
Plasma Lipoproteins Enhance Tissue Factor-Independent Factor VII Activation, Arteriosclerosis, Thrombosis, and Vascular Biology, vol.20, issue.7, pp.1835-1876, 2000. ,
DOI : 10.1161/01.ATV.20.7.1835
HMG CoA reductase inhibitors and the risk of venous thrombosis among postmenopausal women, Journal of Thrombosis and Haemostasis, vol.103, issue.5, pp.700-701, 2004. ,
DOI : 10.1161/01.CIR.103.18.2248
Vascular reactivity, The American Journal of Cardiology, vol.84, issue.1, pp.25-27, 1999. ,
DOI : 10.1016/S0002-9149(99)00354-9
Insulin-mediated skeletal muscle vasodilation is nitric oxide dependent. A novel action of insulin to increase nitric oxide release., Journal of Clinical Investigation, vol.94, issue.3, pp.94-1172, 1994. ,
DOI : 10.1172/JCI117433
URL : http://www.jci.org/articles/view/117433/files/pdf
Platelet inhibition by insulin is absent in type 2 diabetes mellitus, Arterioscler Thromb Vasc Biol, vol.26, pp.417-439, 2006. ,
A Novel Role for CD36 in VLDL-Enhanced Platelet Activation, Diabetes, vol.52, issue.5, pp.52-1248, 2003. ,
DOI : 10.2337/diabetes.52.5.1248
Expression of fatty-acid-handling proteins in human adipose tissue in relation to obesity and insulin resistance, Diabetologia, pp.47-1118, 2004. ,
Distinct roles of GPVI and integrin alpha(2)beta(1) in platelet shape change and aggregation induced by different collagens, Br J Pharmacol, pp.137-107, 2002. ,
Leukocyte Microparticles Stimulate Endothelial Cell Cytokine Release and Tissue Factor Induction in a JNK1 Signaling Pathway, Journal of Biological Chemistry, vol.89, issue.3, pp.274-23111, 1999. ,
DOI : 10.1038/380075a0
Endothelial Dysfunction Caused by Circulating Microparticles from Patients with Metabolic Syndrome, The American Journal of Pathology, vol.173, issue.4, pp.173-1210, 2008. ,
DOI : 10.2353/ajpath.2008.080228
Procoagulant microparticles: disrupting the vascular homeostasis equation?, Arterioscler Thromb Vasc Biol, vol.26, pp.2594-604, 2006. ,
The putative diabetic plasma marker, soluble CD36, is non-cleaved, non-soluble and entirely associated with microparticles, Journal of Thrombosis and Haemostasis, vol.56, issue.Suppl. 2, pp.9-844, 2011. ,
DOI : 10.2337/db07-0394
Leptin receptor missense mutation in the fatty Zucker rat, Nature Genetics, vol.254, issue.1, pp.13-18, 1996. ,
DOI : 10.1016/0092-8674(94)90333-6
Age-dependent changes in blood pressure and arterial reactivity in obese Zucker rats, European Journal of Pharmacology, vol.477, issue.2, pp.477-143, 2003. ,
DOI : 10.1016/j.ejphar.2003.08.003
Arterial stiffness and the autonomic nervous system during the development of Zucker diabetic fatty rats, Diabetes & Metabolism, vol.35, issue.5, pp.35-364, 2009. ,
DOI : 10.1016/j.diabet.2009.02.007
Establishment of a new animal model of metabolic syndrome: SHRSP fatty (fa/fa) rats, Clinical and Experimental Pharmacology and Physiology, vol.52, issue.1-2, pp.31-107, 2004. ,
DOI : 10.1006/bbrc.1995.2631
Cd36 and molecular mechanisms of insulin resistance in the stroke-prone spontaneously hypertensive rat, Diabetes, pp.49-2222, 2000. ,
Characterization of cardiac size and function in SHRSP.Z-Lepr(fa)/IzmDmcr rats, a new animal model of metabolic syndrome, Biol Pharm Bull, pp.33-1971, 2010. ,
Role of Leptin in the Regulation of Glucagon-Like Peptide-1 Secretion, Diabetes, vol.52, issue.2, pp.52-252, 2003. ,
DOI : 10.2337/diabetes.52.2.252
Heterogeneity in the appearance and distribution of macrophage subsets and their possible involvement in hypertensive vascular lesions in rats, Lab Invest, pp.75-125, 1996. ,
Does hypertension confer a hypercoagulable state in stroke-prone spontaneously hypertensive rats?, Journal of Hypertension, vol.18, issue.7, pp.18-901, 2000. ,
DOI : 10.1097/00004872-200018070-00012
Phenotypic consequences of a nonsense mutation in the leptin receptor gene (fak) in obese spontaneously hypertensive Koletsky rats (SHROB), J Nutr, vol.128, pp.2299-306, 1998. ,
Pathologic findings and laboratory data in a new strain of obese hypertensive rats, Am J Pathol, vol.80, pp.129-171, 1975. ,
The SHROB Model of Syndrome X: Effects of Excess Dietary Sucrose, Annals of the New York Academy of Sciences, vol.119, issue.1 THE METABOLIC, pp.892-315, 1999. ,
DOI : 10.1161/01.HYP.24.6.699
Biochemical and morphological characterization of spontaneously hypertensive hyperlipidaemic rats, Clinical and Experimental Pharmacology and Physiology, vol.88, issue.8, pp.537-581, 2003. ,
DOI : 10.1016/0021-9150(91)90255-2
Participation of Neural Factor in the Pathogenesis of Hypertension in the Spontaneously Hypertensive Rat, Japanese Heart Journal, vol.8, issue.2, pp.168-80, 1967. ,
DOI : 10.1536/ihj.8.168
Positional cloning of the mouse obese gene and its human homologue, Nature, pp.372-425, 1994. ,
Mouse models of the metabolic syndrome, Disease Models & Mechanisms, vol.3, issue.3-4, pp.156-66, 2010. ,
DOI : 10.1242/dmm.003467
Restoration of gallstone susceptibility by leptin in C57BL/6J ob/ob mice, J Lipid Res, pp.44-1232, 2003. ,
Mice, Journal of Biological Chemistry, vol.271, issue.7, pp.274-4140, 1999. ,
DOI : 10.1073/pnas.95.13.7385
Obesity induced renal oxidative stress contributes to renal injury in salt-sensitive hypertension, Clin Exp Pharmacol Physiol, vol.36, pp.724-732, 2009. ,
Cardiac lipid accumulation associated with diastolic dysfunction in obese mice, Endocrinology, pp.144-3483, 2003. ,
Impaired cardiac contractile function in ventricular myocytes from leptin-deficient ob/ob obese mice, Journal of Endocrinology, vol.188, issue.1, pp.188-213, 2006. ,
DOI : 10.1677/joe.1.06241
Altered leptin signaling is sufficient, but not required, for hypotension associated with caloric restriction, American Journal of Physiology-Heart and Circulatory Physiology, vol.269, issue.6, pp.281-2473, 2001. ,
DOI : 10.1038/372425a0
Effect of Leptin on Arterial Thrombosis Following Vascular Injury in Mice, JAMA, vol.287, issue.13, pp.287-1706, 2002. ,
DOI : 10.1001/jama.287.13.1706
Recombinant Leptin Promotes Atherosclerosis and Thrombosis in Apolipoprotein E-Deficient Mice, Arteriosclerosis, Thrombosis, and Vascular Biology, vol.25, issue.8, pp.25-119, 2005. ,
DOI : 10.1161/01.ATV.0000173306.47722.ec
Generation and characterization of two novel mouse models exhibiting the phenotypes of the metabolic syndrome: Apob48-/-Lepob/ob mice devoid of ApoE or Ldlr, Am J Physiol Endocrinol Metab, pp.294-496, 2008. ,
A metabolic syndrome of hypertension, hyperinsulinaemia and hypercholesterolaemia in the New Zealand obese mouse, European Journal of Clinical Investigation, vol.31, issue.2, pp.30-195, 2000. ,
DOI : 10.1007/s001250050832
Endothelial Nitric Oxide Synthase Uncoupling and Perivascular Adipose Oxidative Stress and Inflammation Contribute to Vascular Dysfunction in a Rodent Model of Metabolic Syndrome, Hypertension, vol.54, issue.6, pp.54-1384, 2009. ,
DOI : 10.1161/HYPERTENSIONAHA.109.138305
Are hypertensives hypercoagulable?, J Natl Med Assoc, vol.87, pp.71-73, 1995. ,
Elevated Numbers of Tissue-Factor Exposing Microparticles Correlate With Components of the Metabolic Syndrome in Uncomplicated Type 2 Diabetes Mellitus, Circulation, vol.106, issue.19, pp.106-2442, 2002. ,
DOI : 10.1161/01.CIR.0000036596.59665.C6
Tissue factor pathway inhibitor: a new link among arterial stiffness, pulse pressure, and coagulation in postmenopausal women, Arterioscler Thromb Vasc Biol, pp.31-1226, 2011. ,
Gender difference in vascular and platelet reactivity to thromboxane A2-mimetic U46619 and to endothelial dependent vasodilation in Zucker fatty (hypertensive, hyperinsulinemic) diabetic rats, Diabetes Research and Clinical Practice, vol.59, issue.1, pp.59-70, 2003. ,
DOI : 10.1016/S0168-8227(02)00180-8
Development of Hyperfibrinogenemia in Spontaneously Hypertensive and Hyperlipidemic Rats: A Potentially Useful Animal Model as a Complication of Hypertension and Hyperlipidemia, Experimental Animals, vol.56, issue.1, pp.56-57, 2007. ,
DOI : 10.1538/expanim.56.1
Relationship of plasma renin with a prothrombotic state in hypertension: relevance for organ damage, Am J Hypertens, vol.21, pp.1347-53, 2008. ,
Relationship of metabolic syndrome and fibrinolytic dysfunction to cardiovascular disease, Circulation, vol.108, pp.420-425, 2003. ,
Angiotensin II via AT1 receptor accelerates arterial thrombosis in renovascular hypertensive rats, J Physiol Pharmacol, vol.56, pp.571-85, 2005. ,
The Association of the Metabolic Syndrome with PAI-1 and t-PA Levels, Cardiol Res Pract, pp.2011-541467, 2011. ,
Effect of combined AT1 receptor and aldosterone receptor antagonism on plasminogen activator inhibitor-1, J Clin Endocrinol Metab, pp.88-3867, 2003. ,
Changes in fibrinolytic activity after angiotensin II receptor blockade in therapy-resistant hypertensive patients, J Thromb Haemost, vol.5, pp.1509-1524, 2007. ,
Agonistic AT(1) receptor autoantibodies and monocyte stimulation in hypertensive patients, Am J Hypertens, vol.16, pp.827-860, 2003. ,
The Zucker fatty rat as a genetic model of obesity and hypertension., Hypertension, vol.13, issue.6_Pt_2, pp.13-896, 1989. ,
DOI : 10.1161/01.HYP.13.6.896
Increased platelet aggregation in vivo in the Zucker Diabetic Fatty rat: differences from the streptozotocin diabetic rat, British Journal of Pharmacology, vol.41, issue.(Suppl), pp.150-105, 2007. ,
DOI : 10.2337/diab.41.2.S26
Increased aortic stiffness in the insulin-resistant Zucker fa/fa rat, Am J Physiol Heart Circ Physiol, pp.289-845, 2005. ,
Animal model: obese hypertensive rat, Am J Pathol, vol.81, pp.463-469, 1975. ,